Basic Information
PANVAX® PANDEMIC INFLUENZA VACCINE (ADJUVANTED) 10ML SUSPENSION FOR INJECTION VIAL
INJECTION, SUSPENSION
Regulatory Information
SIN15801P
September 6, 2019
Prescription Only
Therapeutic
INTRAMUSCULAR
August 10, 2023
June 4, 2025
XJ07BB02
Company Information
Active Ingredients
Strength: 30 mcg HA / 0.5 ml
Detailed Information
Contraindications
**Contraindications** History of an anaphylactic (i.e. life-threatening) reaction to any of the constituents or trace residues (e.g. eggs, chicken protein refer to sections **Qualitative and Quantitative Composition** and **List of excipients** – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_) of this vaccine. However, in a pandemic situation, it may be appropriate to give the vaccine, provided that facilities for resuscitation are immediately available in case of need.
Indication Information
**Therapeutic indications** Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with Singaporean Health Authorities’ recommendations, taking into account the recommendation of the World Health Organisation.